New study aims to uncover hidden superbug threat in transplant patients

NCT ID NCT07324291

Not yet recruiting Knowledge-focused Sponsor: Institute of Hematology & Blood Diseases Hospital, China Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study will follow 1,000 adults who have received a stem cell transplant to track a type of antibiotic-resistant bacteria called MBL-CRE. Researchers will use regular swab tests to see how often patients carry these bacteria and how often they develop infections. The goal is to better understand the risks and resistance patterns to improve future prevention and treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could help doctors predict and prevent dangerous infections in stem cell transplant patients.

What could go wrong

This is an observational study, not a treatment trial. It will not directly benefit participants and may not lead to immediate changes in care.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION CARBAPENEM-RESISTANT ENTEROBACTERALES